PsyBio Therapeutics Corp. engages in the development of drugs intended for the treatment of mental health challenges and other disorders. The company was founded on October 28, 2009 and is headquartered in Sunrise, FL.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of PsyBio Therapeutics Corp?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. PsyBio Therapeutics Corp market cap is $0.00.
What is the 52-week high for PsyBio Therapeutics Corp?
52 week high is the highest price of a stock in the past 52 weeks, or one year. PsyBio Therapeutics Corp 52 week high is $0.021 as of October 10, 2025.
What is the 52-week low for PsyBio Therapeutics Corp?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. PsyBio Therapeutics Corp 52 week low is $0.00 as of October 10, 2025.
What is the 50-day moving average of PsyBio Therapeutics Corp?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. PsyBio Therapeutics Corp 50-day moving average is $0.00.